|
Index of reports
> Cases resulting in hospitalization (29)
> Cases with Peripheral Ischaemia (4)
Below is the selection of adverse event reports related to Symbicort (Budesonide Inhalation) that includes cases resulting in hospitalization where reactions include peripheral ischaemia.
Adverse event in 47 year old female receiving Symbicort (Budesonide Inhalation)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-31
Patient: 47 year old female
Adverse reactions / side effects: Peripheral Ischaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Medrol
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-23
Symbicort
Dosage: daily dose:800mg
Indication: Bronchitis
Clarithromycin
Dosage: text:1 g
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-25
Cetirizine HCL
Administration route: Oral
Other drugs received by patient: Paracetamol; Tiotropium
Adverse event in 47 year old female receiving Symbicort (Budesonide Inhalation)
Reported by a health professional (non-physician/pharmacist) from France on 2007-05-16
Patient: 47 year old female
Adverse reactions / side effects: Peripheral Ischaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Symbicort
Dosage: 320/9 ?g per dose, two inhalations per day
Indication: Bronchitis
Monozeclar
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-25
Medrol
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-23
Cetirizine HCL
Administration route: Oral
Indication: Bronchitis
Other drugs received by patient: Paracetamol
Adverse event in 47 year old female receiving Symbicort (Budesonide Inhalation)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-22
Patient: 47 year old female
Adverse reactions / side effects: Peripheral Ischaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Medrol
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-23
Symbicort
Dosage: daily dose:800mg-freq:interval: everyday
Indication: Bronchitis
Clarithromycin
Dosage: text:1 g-freq:interval: everyday
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-25
Cetirizine HCL
Administration route: Oral
Other drugs received by patient: Paracetamol; Tiotropium
Adverse event in 47 year old female receiving Symbicort (Budesonide Inhalation)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-25
Patient: 47 year old female
Adverse reactions / side effects: Peripheral Ischaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Symbicort
Dosage: 320/9 ?g per dose, two inhalations per day
Indication: Bronchitis
Monozeclar
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-25
Medrol
Administration route: Oral
Indication: Bronchitis
Start date: 2006-12-18
End date: 2006-12-23
Cetirizine HCL
Administration route: Oral
Indication: Bronchitis
Other drugs received by patient: Paracetamol
|
